We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
(+4.1%)
Cap. Flow
-$8.05B
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.24B |
| 2 |
Palo Alto Networks
PANW
|
+$489M |
| 3 |
Tesla
TSLA
|
+$372M |
| 4 |
Qualcomm
QCOM
|
+$361M |
| 5 |
Broadcom
AVGO
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.18B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Amazon
AMZN
|
+$544M |
| 4 |
Apple
AAPL
|
+$540M |
| 5 |
Meta Platforms (Facebook)
META
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.36% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Entravision Communication
EVC
$1.1B
| $7.92M | ﹤0.01% |
1,262,515
-27,564
| -2% | -$208K |
|
1827
Arbutus Biopharma
ABUS
$915M
| $7.89M | ﹤0.01% |
2,011,809
+892,198
| +80% | +$3.47M |
|
1828
Stoneridge
SRI
$213M
| $7.86M | ﹤0.01% |
370,279
-97,499
| -21% | -$2.06M |
|
|
TEN
1829
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $7.86M | ﹤0.01% |
795,296
-195,832
| -20% | -$2.45M |
|
1830
Kodiak Sciences
KOD
$2.84B
| $7.86M | ﹤0.01% |
98,223
-10,848
| -10% | -$1.1M |
|
|
VIVO
1831
DELISTED
Meridian Bioscience Inc
VIVO
| $7.83M | ﹤0.01% |
383,658
-184,311
| -32% | -$3.53M |
|
1832
Fiverr
FVRR
$339M
| $7.83M | ﹤0.01% |
+68,818
| New | +$10.7M |
|
1833
Scholastic
SCHL
$792M
| $7.82M | ﹤0.01% |
195,623
-32,559
| -14% | -$1.23M |
|
|
CELL
1834
DELISTED
PhenomeX Inc. Common Stock
CELL
| $7.79M | ﹤0.01% |
455,016
-16,034
| -3% | -$346K |
|
1835
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $7.76M | ﹤0.01% |
487,520
-23,417
| -5% | -$384K |
|
1836
Axcelis
ACLS
$4.33B
| $7.75M | ﹤0.01% |
123,505
-9,545
| -7% | -$566K |
|
1837
Marten Transport
MRTN
$1.22B
| $7.75M | ﹤0.01% |
460,169
-422,415
| -48% | -$6.99M |
|
|
GCP
1838
DELISTED
GCP Applied Technologies Inc.
GCP
| $7.75M | ﹤0.01% |
244,002
-17,328
| -7% | -$442K |
|
|
GES
1839
DELISTED
Guess Inc
GES
| $7.72M | ﹤0.01% |
346,470
-31,405
| -8% | -$695K |
|
1840
Ligand Pharmaceuticals
LGND
$6.36B
| $7.71M | ﹤0.01% |
88,878
-6,784
| -7% | -$627K |
|
1841
FuelCell Energy
FCEL
$1.63B
| $7.69M | ﹤0.01% |
41,403
+3,272
| +9% | +$771K |
|
1842
Costamare
CMRE
$1.77B
| $7.69M | ﹤0.01% |
672,300
+31,594
| +5% | +$413K |
|
1843
Astrana Health
ASTH
$1.77B
| $7.69M | ﹤0.01% |
107,502
-10,384
| -9% | -$853K |
|
1844
Standard BioTools
LAB
$314M
| $7.66M | ﹤0.01% |
1,955,086
+23,251
| +1% | +$109K |
|
1845
Allegiant Air
ALGT
$2.57B
| $7.65M | ﹤0.01% |
44,686
-4,923
| -10% | -$914K |
|
1846
SkinHealth Systems
SKIN
$85.7M
| $7.65M | ﹤0.01% |
359,953
-220,885
| -38% | -$5.69M |
|
1847
Plains GP Holdings
PAGP
$4.9B
| $7.64M | ﹤0.01% |
753,858
-471,676
| -38% | -$5.08M |
|
1848
AZZ Inc
AZZ
$4.54B
| $7.62M | ﹤0.01% |
144,955
-7,984
| -5% | -$433K |
|
1849
ADT
ADT
$5.58B
| $7.61M | ﹤0.01% |
904,467
-317,144
| -26% | -$2.7M |
|
1850
CorVel
CRVL
$3.19B
| $7.59M | ﹤0.01% |
109,470
-6,516
| -6% | -$409K |
|
Similar funds
VFT
Nuveen's Q4 2021 Portfolio in Review
As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
- Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
- Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
- Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
- Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
- Nuveen opened 75 new positions and closed 162 in Q4 2021.
- Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.
Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.